$DCTH
Delcath Systems Inc Stock $dcth

$dcth Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-Q Financial Statement

#000156459020053324 Filed on November 12, 2020

Income Statement

Concept	2020 Q3	2019 Q3	2019 Q2
Revenue	$470.0K	$380.0K	$410.0K
YoY Change	23.68%	-53.88%	-52.21%
Cost Of Revenue	$190.0K	$170.0K	$172.0K
YoY Change	11.76%	-27.04%	-21.82%
Gross Profit	$280.0K	$208.0K	$240.0K
YoY Change	34.62%	-64.81%	-62.38%
Gross Profit Margin	59.57%	54.74%	58.54%
Selling, General & Admin	$2.000M	$4.002M	$2.653M
YoY Change	-50.02%	75.6%	0.49%
% of Gross Profit	714.29%	1924.04%	1105.42%
Research & Development	$3.260M	$1.780M	$1.714M
YoY Change	83.15%	-56.65%	-58.08%
% of Gross Profit	1164.29%	855.77%	714.17%
Depreciation & Amortization	$40.00K	$100.0K	$100.0K
YoY Change	-60.0%	0.0%	0.0%
% of Gross Profit	14.29%	48.08%	41.67%
Operating Expenses	$5.260M	$5.780M	$4.367M
YoY Change	-9.0%	-9.48%	-35.11%
Operating Profit	-$4.980M	-$5.572M	-$4.127M
YoY Change	-10.62%	-3.83%	-32.26%
Interest Expense	-$40.00K	-$1.950M	-$1.837M
YoY Change	-97.95%	-38.11%	228.04%
% of Operating Profit
Other Income/Expense, Net	$33.00K	$4.000K	$1.000K
YoY Change	725.0%	-140.0%	-120.0%
Pretax Income	-$4.990M	-$7.520M	-$5.960M
YoY Change	-33.64%	-15.32%	-10.51%
Income Tax
% Of Pretax Income
Net Earnings	-$4.991M	-$7.520M	-$5.959M
YoY Change	-33.63%	-15.32%	-10.5%
Net Earnings / Revenue	-1061.91%	-1978.95%	-1453.41%
Basic Earnings Per Share		-$0.41	-$58.50
Diluted Earnings Per Share	-$1.163M	-$1.41	-$58.50
COMMON SHARES
Basic Shares Outstanding	3.936M	18.28M	101.9K
Diluted Shares Outstanding		18.28M	101.9K

Balance Sheet

Concept	2020 Q3	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.90M	$15.33M	$350.0K
YoY Change	-28.9%	72.05%	-72.66%
Cash & Equivalents	$11.08M	$15.52M	$352.0K
Short-Term Investments
Other Short-Term Assets	$2.040M	$1.040M	$1.720M
YoY Change	96.15%	-27.78%	21.99%
Inventory	$840.0K	$740.0K	$687.0K
Prepaid Expenses
Receivables	$100.0K	$10.00K	$180.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.88M	$17.13M	$2.945M
YoY Change	-18.97%	44.92%	-32.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.420M	$1.770M	$805.0K
YoY Change	36.72%	75.25%	-26.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$270.0K
YoY Change
Total Long-Term Assets	$2.690M	$1.765M	$2.691M
YoY Change	52.41%	74.75%	143.97%
TOTAL ASSETS
Total Short-Term Assets	$13.88M	$17.13M	$2.945M
Total Long-Term Assets	$2.690M	$1.765M	$2.691M
Total Assets	$16.57M	$18.90M	$5.636M
YoY Change	-12.3%	47.27%	2.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.500M	$4.871M	$10.71M
YoY Change	-69.21%	-28.16%	91.06%
Accrued Expenses	$6.640M	$6.537M	$9.119M
YoY Change	1.58%	96.31%	74.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$9.840M
YoY Change
Long-Term Debt Due	$2.000M	$0.00	$520.0K
YoY Change		-100.0%	33.33%
Total Short-Term Liabilities	$10.64M	$32.47M	$31.25M
YoY Change	-67.23%	90.44%	72.66%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$2.000M	$0.00
YoY Change	-100.0%	1566.67%	-100.0%
Other Long-Term Liabilities	$2.650M	$3.250M	$122.0K
YoY Change	-18.46%	513.21%	-72.21%
Total Long-Term Liabilities	$2.650M	$5.250M	$122.0K
YoY Change	-49.52%	707.69%	-72.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.64M	$32.47M	$31.25M
Total Long-Term Liabilities	$2.650M	$5.250M	$122.0K
Total Liabilities	$13.29M	$37.72M	$35.37M
YoY Change	-64.77%	113.11%	90.51%
SHAREHOLDERS EQUITY
Retained Earnings		-$383.7M	-$357.9M
YoY Change			10.36%
Common Stock		$183.0K	$183.0K
YoY Change			1933.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.276M	-$18.83M	-$29.73M
YoY Change
Total Liabilities & Shareholders Equity	$16.57M	$18.90M	$5.636M
YoY Change	-12.3%	47.27%	2.98%

Cashflow Statement

Concept	2020 Q3	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	-$4.991M	-$7.520M	-$5.959M
YoY Change	-33.63%	-15.32%	-10.5%
Depreciation, Depletion And Amortization	$40.00K	$100.0K	$100.0K
YoY Change	-60.0%	0.0%	0.0%
Cash From Operating Activities	-$5.190M	-$12.36M	-$3.190M
YoY Change	-58.01%	242.38%	12.32%
INVESTING ACTIVITIES
Capital Expenditures	-$490.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$490.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	660.0K	26.46M	3.320M
YoY Change	-97.51%	143.42%	38.33%
NET CHANGE
Cash From Operating Activities	-5.190M	-12.36M	-3.190M
Cash From Investing Activities	-490.0K	0.000	0.000
Cash From Financing Activities	660.0K	26.46M	3.320M
Net Change In Cash	-5.020M	14.10M	130.0K
YoY Change	-135.6%	94.75%	-127.66%
FREE CASH FLOW
Cash From Operating Activities	-$5.190M	-$12.36M	-$3.190M
Capital Expenditures	-$490.0K	$0.00	$0.00
Free Cash Flow	-$4.700M	-$12.36M	-$3.190M
YoY Change	-61.97%	244.29%	13.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2020Q3	dcth	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	268000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67091
CY2019Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2000000
CY2020Q3	us-gaap	Liabilities Liabilities	13289000
CY2019Q4	us-gaap	Liabilities Liabilities	20569000
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	21473
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	41517
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	21473
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	41517
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4035558
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67091
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4035558
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	482000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2832000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-451000
CY2019Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1714000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1721000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-154000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4735000
CY2020Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	33000
CY2019Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4000
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	182000
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4000
	us-gaap	Net Income Loss NetIncomeLoss	-17127000
	us-gaap	Net Income Loss NetIncomeLoss	-21371000
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	-55000
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7519000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-17182000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-21371000
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	1:700
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.00142
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	25000
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	30000
CY2020Q1	dcth	Adjustment To Additional Paid In Capital Registration Of Preferred Stock And Related Warrants AdjustmentToAdditionalPaidInCapitalRegistrationOfPreferredStockAndRelatedWarrants	-106000
CY2020Q1	dcth	Adjustments To Additional Paid In Capital Fair Value Of Warrants Reclassified From Liability To Equity AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsReclassifiedFromLiabilityToEquity	6199000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7861000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	65000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-8005000
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	606000
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-1000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-103000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-14939000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	54000
CY2020Q2	dcth	Issuance Of Common Stock And Warrants In Public Offering IssuanceOfCommonStockAndWarrantsInPublicOffering	19378000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-4275000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	7702000
CY2020Q3	dcth	Stock Issued During Period Value Exchange Of Warrants For Common Stock StockIssuedDuringPeriodValueExchangeOfWarrantsForCommonStock	602000
CY2020Q3	dcth	Atm Offering ATMOffering	66000
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	4000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	150000
CY2019Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	-1160000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	-23778000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	75000
CY2019Q2	dcth	Stock Issued During Period Value Exchange Of Warrants For Common Stock StockIssuedDuringPeriodValueExchangeOfWarrantsForCommonStock	13000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-5959000
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-80000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-29729000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	70000
CY2019Q3	dcth	Issuance Of Series E Preferred Stock IssuanceOfSeriesEPreferredStock	29575000
CY2019Q3	dcth	Issuance Of Series E1 Preferred Stock IssuanceOfSeriesE1PreferredStock	9510000
CY2019Q3	dcth	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	-20844000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	112000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	-18825000
	dcth	Stock Option Compensation Income Expense StockOptionCompensationIncomeExpense	25000
	dcth	Stock Option Compensation Income Expense StockOptionCompensationIncomeExpense	199000
	dcth	Restricted Stock Compensation Income Expense RestrictedStockCompensationIncomeExpense	406000
	dcth	Restricted Stock Compensation Income Expense RestrictedStockCompensationIncomeExpense	4000
	us-gaap	Depreciation Depreciation	125000
	us-gaap	Depreciation Depreciation	168000
	dcth	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	492000
	dcth	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	1535000
	dcth	Interest Income Earned On Money Market And Operating Accounts InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts	0
	dcth	Interest Income Earned On Money Market And Operating Accounts InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts	23000
	dcth	Equitization Of Expenses EquitizationOfExpenses	0
	dcth	Equitization Of Expenses EquitizationOfExpenses	1474000
	dcth	Loss On Issuance Of Financial Instruments LossOnIssuanceOfFinancialInstruments	0
	dcth	Loss On Issuance Of Financial Instruments LossOnIssuanceOfFinancialInstruments	1715000
	us-gaap	Paid In Kind Interest PaidInKindInterest	120000
	us-gaap	Paid In Kind Interest PaidInKindInterest	33000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4467000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	100000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-43000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	82000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-564000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	185000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-85000
	dcth	Increase Decrease In Deferred Offering Costs IncreaseDecreaseInDeferredOfferingCosts	268000
	dcth	Increase Decrease In Deferred Offering Costs IncreaseDecreaseInDeferredOfferingCosts	0
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3784000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4289000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-256000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-360000
	dcth	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-466000
	dcth	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1488000
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-627000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	49000
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3719000
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	106000
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	0
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	19377000
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	601000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30330000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-69000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11937000
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15515000
	us-gaap	Interest Paid Net InterestPaidNet	7000
	us-gaap	Interest Paid Net InterestPaidNet	4000
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	20000
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0
	dcth	Reclassification Of Warrants From Liability To Equity ReclassificationOfWarrantsFromLiabilityToEquity	6199000
	dcth	Reclassification Of Warrants From Liability To Equity ReclassificationOfWarrantsFromLiabilityToEquity	0
	dcth	Exchange Of Warrants ExchangeOfWarrants	0
	dcth	Exchange Of Warrants ExchangeOfWarrants	13000
	dcth	Non Cash Activities Fair Value Of Warrants Issued NonCashActivitiesFairValueOfWarrantsIssued	0
	dcth	Non Cash Activities Fair Value Of Warrants Issued NonCashActivitiesFairValueOfWarrantsIssued	20844000
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1652000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	729000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	874000
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period balances have been reclassified in order to conform to current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share.</p>
CY2020Q3	dcth	Deferred Offering Costs Unamortized DeferredOfferingCostsUnamortized	268000
CY2020Q3	dcth	Letters Of Credit Restricted Cash LettersOfCreditRestrictedCash	131000
CY2019Q4	dcth	Letters Of Credit Restricted Cash LettersOfCreditRestrictedCash	131000
CY2020Q3	dcth	Security For Credit Cards Restricted Cash SecurityForCreditCardsRestrictedCash	50000
CY2019Q4	dcth	Security For Credit Cards Restricted Cash SecurityForCreditCardsRestrictedCash	50000
CY2020Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	376000
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	375000
CY2020Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	463000
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	279000
CY2020Q3	dcth	Prepaid Clinical Trial Expenses Current PrepaidClinicalTrialExpensesCurrent	1497000
CY2019Q4	dcth	Prepaid Clinical Trial Expenses Current PrepaidClinicalTrialExpensesCurrent	725000
CY2020Q3	us-gaap	Prepaid Insurance PrepaidInsurance	63000
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	589000
CY2020Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	300000
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	445000
CY2020Q3	dcth	Maximum Percentage Of Prepaid Expenses And Other Current Assets MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets	0.05
CY2019Q4	dcth	Maximum Percentage Of Prepaid Expenses And Other Current Assets MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets	0.05
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5970000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5246000
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4652000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4511000
CY2020Q3	dcth	Exercised Option To Purchase ExercisedOptionToPurchase	460300
CY2020Q3	dcth	Property Plant And Equipment Depreciation Expense PropertyPlantAndEquipmentDepreciationExpense	32700
CY2020Q3	dcth	Accrued Clinical Expenses Current AccruedClinicalExpensesCurrent	2919000
	dcth	Property Plant And Equipment Depreciation Expense PropertyPlantAndEquipmentDepreciationExpense	124700
CY2019Q3	dcth	Property Plant And Equipment Depreciation Expense PropertyPlantAndEquipmentDepreciationExpense	45800
	dcth	Property Plant And Equipment Depreciation Expense PropertyPlantAndEquipmentDepreciationExpense	168000
CY2019Q4	dcth	Accrued Clinical Expenses Current AccruedClinicalExpensesCurrent	2497000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2832000
	dcth	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Fair Value Of Warrants Reclassified From Liability To Equity FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFairValueOfWarrantsReclassifiedFromLiabilityToEquity	6200000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6285554
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2037313
	dcth	Number Of Shares Pre Funded Penny Warrants Outstanding NumberOfSharesPreFundedPennyWarrantsOutstanding	371000
CY2020Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	68000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1191000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	93000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1098000
	us-gaap	Operating Lease Cost OperatingLeaseCost	509000
	dcth	Financing Lease Cost FinancingLeaseCost	27000
	dcth	Finance Lease Principal Payment On Liability FinanceLeasePrincipalPaymentOnLiability	26000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	173000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	544000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	406000
CY2020Q1	dcth	Common Stock Offering Period Of Restriction Common Stock CommonStockOfferingPeriodOfRestrictionCommonStock	P2Y
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	2000224
	dcth	Stock Issued During Period Shares Exercise Of Pre Funded Warrants StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants	6000
	dcth	Stock Issued During Period Shares Associated Other Warrants StockIssuedDuringPeriodSharesAssociatedOtherWarrants	60117
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	72976
CY2020Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	675000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1640
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1141
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	499
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2499000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3525000
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	667000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	925000
CY2020Q3	dcth	Maximum Percentage Of Current Liabilities Accrued MaximumPercentageOfCurrentLiabilitiesAccrued	0.05
CY2019Q4	dcth	Maximum Percentage Of Current Liabilities Accrued MaximumPercentageOfCurrentLiabilitiesAccrued	0.05
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	499
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	196.70
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	196.70
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	196.70
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y4M24D
CY2020Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0
CY2019Q3	dcth	Share Based Compensation Income Expense ShareBasedCompensationIncomeExpense	70000
	dcth	Share Based Compensation Income Expense ShareBasedCompensationIncomeExpense	660000
	dcth	Share Based Compensation Income Expense ShareBasedCompensationIncomeExpense	203000
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1826608
	dcth	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	2601900
	dcth	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	66117
	dcth	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	18
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4362373
CY2019Q4	dcth	Class Of Warrant Or Right Weighted Average Exercise Price ClassOfWarrantOrRightWeightedAverageExercisePrice	23.04
	dcth	Class Of Warrant Or Right Weighted Average Exercise Price Issued ClassOfWarrantOrRightWeightedAverageExercisePriceIssued	10.00
	dcth	Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod	9.09
	dcth	Class Of Warrant Or Right Weighted Average Exercise Price Expirations In Period ClassOfWarrantOrRightWeightedAverageExercisePriceExpirationsInPeriod	7.00
CY2020Q3	dcth	Class Of Warrant Or Right Weighted Average Exercise Price ClassOfWarrantOrRightWeightedAverageExercisePrice	9.15
CY2019	dcth	Class Of Warrant Or Right Weighted Average Remaining Contractual Term ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm	P5Y
	dcth	Class Of Warrant Or Right Weighted Average Remaining Contractual Term ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm	P4Y6M
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.00
CY2020Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	22000000
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3368000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3917593
CY2019Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	25587
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2015863
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	26681
CY2020Q3	dcth	Weighted Average Number Of Shares Pre Funded Warrants1 WeightedAverageNumberOfSharesPreFundedWarrants1	371000
CY2019Q3	dcth	Weighted Average Number Of Shares Pre Funded Warrants1 WeightedAverageNumberOfSharesPreFundedWarrants1	76275
	dcth	Weighted Average Number Of Shares Pre Funded Warrants1 WeightedAverageNumberOfSharesPreFundedWarrants1	201748
	dcth	Weighted Average Number Of Shares Pre Funded Warrants1 WeightedAverageNumberOfSharesPreFundedWarrants1	76275
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4288593
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	101862
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2217611
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	102956
	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	(i) the 2014 Sublease and 2015 Sublease were extended from May 31, 2020 to August 2, 2021, (ii) effective July 1, 2020, the leased premises under the 2015 Sublease would be expanded to include an additional 4,999 square feet of space, and (iii) effective July 1, 2020, the rent under the 2015 Sublease would increase from approximately $14.6 per month to $20.6 per month.
CY2020Q3	us-gaap	Lessor Operating Lease Option To Extend LessorOperatingLeaseOptionToExtend	May 31, 2020 to August 2, 2021
CY2020Q2	us-gaap	Lease Cost LeaseCost	0
CY2020Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-02-28

Files In Submission

Name	View Source	Status
0001564590-20-053324-index-headers.html	Edgar Link	pending
0001564590-20-053324-index.html	Edgar Link	pending
0001564590-20-053324.txt	Edgar Link	pending
0001564590-20-053324-xbrl.zip	Edgar Link	pending
dcth-10q_20200930.htm	Edgar Link	pending
dcth-20200930.xml	Edgar Link	completed
dcth-20200930.xsd	Edgar Link	pending
dcth-20200930_cal.xml	Edgar Link	unprocessable
dcth-20200930_def.xml	Edgar Link	unprocessable
dcth-20200930_lab.xml	Edgar Link	unprocessable
dcth-20200930_pre.xml	Edgar Link	unprocessable
dcth-ex104_267.htm	Edgar Link	pending
dcth-ex311_9.htm	Edgar Link	pending
dcth-ex312_8.htm	Edgar Link	pending
dcth-ex321_6.htm	Edgar Link	pending
dcth-ex322_7.htm	Edgar Link	pending
dcth-ex994_374.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DCTH
Delcath Systems Inc Stock $dcth

2020 Q3 Form 10-Q Financial Statement

#000156459020053324 Filed on November 12, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DCTH Delcath Systems Inc Stock $dcth

2020 Q3 Form 10-Q Financial Statement

#000156459020053324 Filed on November 12, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DCTH
Delcath Systems Inc Stock $dcth